Profiling of nutrient transporter expression in human stem cell-derived cardiomyocytes exposed to tyrosine kinase inhibitor anticancer drugs using RBD ligands

Journal of Biomolecular Screening

Volumn 19, Issue 8, 2014, Pages 1185-1192

  Li, Jianliang ^a   Cousin, Christelle ^b   Tinkler, Hayley ^a   Touhami, Jawida ^b   Petit, Vincent ^b   Thomas, Nick ^a  

^a GE HEALTHCARE   (United Kingdom)

^b Parc Scientifique de Luminy   (France)

Author keywords

cardiomyocytes; high content screening; nutrient transporters

Indexed keywords

AMIODARONE; ANTIMYCIN A1; ANTINEOPLASTIC AGENT; GALACTOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; IMATINIB; LIGAND; MUBRITINIB; NIFEDIPINE; NUTRIENT TRANSPORTER; PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR BINDING DOMAIN LIGAND; SORAFENIB; SUNITINIB; TOFACITINIB; UNCLASSIFIED DRUG; CARRIER PROTEIN; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; SLC2A1 PROTEIN, HUMAN;

ARTICLE; CELL METABOLISM; CELL SURFACE; CLUSTER ANALYSIS; CONTROLLED STUDY; FLOW CYTOMETRY; GLYCOLYSIS; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IC 50; MITOCHONDRIAL TOXICITY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; STEM CELL; ANTAGONISTS AND INHIBITORS; BINDING SITE; CARDIAC MUSCLE CELL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; METABOLISM; PROCEDURES; PROTEIN DOMAIN; RADIATION RESPONSE; TOXICITY TESTING;

ANTINEOPLASTIC AGENTS; BINDING SITES; CARRIER PROTEINS; CELLS, CULTURED; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LIGANDS; MYOCYTES, CARDIAC; OXIDATIVE PHOSPHORYLATION; PROTEIN DOMAINS; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; STEM CELLS; TOXICITY TESTS;

EID: 84905593984     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057114533724     Document Type: Article

References (33)

1. Hediger M. A., Clémençon B., Burrier R. E., et al. The ABCs of Membrane Transporters in Health and Disease (SLC Series): Introduction. Mol. Aspects. Med. 2013 ; 34 (2-3). 95-107
2. Montel-Hagen A. L., Blanc M., Boyer-Clavel C., et al. The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood. 2008 ; 112: 4729-4738
3. Indo Y., Takeshita S., Ishii K. A., et al. Metabolic Regulation of Osteoclast Differentiation and Function. J. Bone. Miner. Res. 2013 ; 28: 2392-2399
4. Ganapathy V., Thangaraju M., Prasad P. D.. Nutrient Transporters in Cancer: Relevance to Warburg Hypothesis and Beyond. Pharmacol. Ther. 2009 ; 121: 29-40
5. Swainson L., Kinet S., Manel N., et al. Glucose Transporter 1 Expression Identifies a Population of Cycling CD4+ CD8+ Human Thymocytes with High CXCR4-Induced Chemotaxis. Proc. Natl. Acad. Sci. U.S.A. 2005 ; 102: 12867-12872
6. Beck L., Leroy C., Salaün C., et al. Identification of a Novel Function of PiT1 Critical for Cell Proliferation and Independent of Its Phosphate Transport Activity. J. Biol. Chem. 2009 ; 284: 31363-31374
7. Beck L., Leroy C., Beck-Cormier S., et al. The Phosphate Transporter PiT1 (Slc20a1) Revealed as a New Essential Gene for Mouse Liver Development. PLoS One. 2010 ; 5 (2). e9148
8. Kim F. J., Battini J. L., Manel N., et al. Emergence of Vertebrate Retroviruses and Envelope Capture. Virology. 2004 ; 318: 183-191
9. Loisel-Meyer S. L., Swainson M., Craveiro L., et al. Glut1-Mediated Glucose Transport Regulates HIV Infection. Proc. Natl. Acad. Sci. U.S.A. 2012 ; 109: 2549-2554
10. Kinet S., Swainson L., Lavanya M., et al. Isolated Receptor Binding Domains of HTLV-1 and HTLV-2 Envelopes Bind Glut-1 on Activated CD4+ and CD8+ T Cells. Retrovirology. 2007 ; 4: 31
11. Yonezawa A., Masuda S., Katsura T., et al. Identification and Functional Characterization of a Novel Human and Rat Riboflavin Transporter, RFT1. Am. J. Physiol. Cell. Physiol. 2008 ; 295: C632 - C641
12. Bunprajun T., Henriksen T. I., Scheele C., et al. Lifelong Physical Activity Prevents Aging-Associated Insulin Resistance in Human Skeletal Muscle Myotubes via Increased Glucose Transporter Expression. PLoS. One. 2013 ; 8: e66628
13. Manel N., Kim F. J., Kinet S., et al. The Ubiquitous Glucose Transporter GLUT-1 Is a Receptor for HTLV. Cell. 2003 ; 115: 449-459
14. Lagrue E., Abe H., Lavanya M., et al. Regional Characterization of Energy Metabolism in the Brain of Normal and MPTP-Intoxicated Mice Using New Markers of Glucose and Phosphate Transport. J. Biomed. Sci. 2010 ; 17: 91
15. Petit V., Massonnet G., Maciorowski Z., et al. Optimization of Tumor Xenograft Dissociation for the Profiling of Cell Surface Markers and Nutrient Transporters. Lab. Invest. 2013 ; 93: 611-621
16. Laval J., Touhami J., Herzenberg L. A., et al. Metabolic Adaptation of Neutrophils in Cystic Fibrosis Airways Involves Distinct Shifts in Nutrient Transporter Expression. J. Immunol. 2013 ; 190: 6043-6050
17. Montel-Hagen A., Kinet S., Manel N., et al. Erythrocyte Glut1 Triggers Dehydroascorbic Acid Uptake in Mammals Unable to Synthesize Vitamin C. Cell. 2008 ; 132: 1039-1048
18. Giovannini D., Touhami J., Charnet P., et al. Inorganic Phosphate Export by the Retrovirus Receptor XPR1 in Metazoans. Cell. Rep. 2013 ; 3: 1866-1873
19. Lemieux H., Hoppel C. L.. Mitochondria in the Human Heart. J. Bioenerg. Biomembr. 2009 ; 41: 99-106
20. Force T., Krause D. S., Van Etten R. A.. Molecular Mechanisms of Cardiotoxicity of Tyrosine Kinase Inhibition. Nat. Rev. Cancer. 2007 ; 7: 332-344
21. Dykens J. A., Will Y.. The Significance of Mitochondrial Toxicity Testing in Drug Development. Drug Discov. Today. 2007 ; 12: 777-785
22. Taegtmeyer H.. Switching Metabolic Genes to Build a Better Heart. Circulation. 2002 ; 106: 2043-2045
23. Marroquin L. D., Hynes J., Dykens J. A., et al. Circumventing the Crabtree Effect: Replacing Media Glucose with Galactose Increases Susceptibility of HepG2 Cells to Mitochondrial Toxicants. Toxicol. Sci. 2007 ; 97: 539-547
24. ThomasN.HatherC.KaussA.. Bioenergetic Modulation of Kinase Inhibitor Mitochondrial Toxicity in hESC Derived Cardiomyocytes. Manuscript submitted for publication.
25. Will Y., Dykens J. A., Nadanaciva S., et al. Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells. Toxicol. Sci. 2008 ; 106: 153-161
26. Battini J. L., Rasko J. E., Miller A. D.. A Human Cell-Surface Receptor for Xenotropic and Polytropic Murine Leukemia Viruses: Possible Role in G Protein-Coupled Signal Transduction. Proc. Natl. Acad. Sci. U.S.A. 1999 ; 96: 1385-1390
27. Peng S., Lacerda A. E., Kirsch G. E., et al. The Action Potential and Comparative Pharmacology of Stem Cell-Derived Human Cardiomyocytes. J. Pharmacol. Toxicol. Methods. 2010 ; 61: 277-286
28. Pointon A., Abi-Gerges N., Cross M. J., et al. Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity. Toxicol. Sci. 2013 ; 132: 317-326
29. Cura A. J., Carruthers A.. The Role of Monosaccharide Transport Proteins in Carbohydrate Assimilation, Distribution, Metabolism and Homeostasis. Compr. Physiol. 2012 ; 2: 863-914
30. Chi K. R.. Revolution Dawning in Cardiotoxicity Testing. Nat. Rev. Drug Discov. 2013 ; 12: 565-567
31. Nagasawa J., Mizokami A., Koshida K., et al. Novel HER2 Selective Tyrosine Kinase Inhibitor, TAK-165, Inhibits Bladder, Kidney and Androgen-Independent Prostate Cancer In Vitro and In Vivo. Int. J. Urol. 2006 ; 13: 587-592
32. U.S. National Institutes of Health Clinical Trials. http:// clinicaltrials.gov/ct2/show/NCT00034281?term=TAK165&rank=1 (accessed Jan 2014).
33. Khan A. A., Quigley J. G.. Heme and FLVCR-Related Transporter Families SLC48 and SLC49. Mol. Aspects. Med. 2013 ; 34: 669-682